Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 July 2016Website:
http://www.pavmed.comNext earnings report:
16 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 21:39:07 GMTDividend
Analysts recommendations
Institutional Ownership
PAVM Latest News
A conference call and webcast will be held at 8:30 AM Eastern Time on May 14, 2024 by PAVmed Inc. to provide a business update.
PAVmed Inc. (PAVM) ended the most recent trading session at $2.07, showing a decrease of 1.43% from the previous day.
PAVmed Inc. (NASDAQ:PAVM ) Q3 2023 Earnings Call Transcript November 15, 2023 8:30 AM ET Company Participants Michael Parks - Vice President of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Ed Woo - Ascendiant Capital Anthony Vendetti - Maxim Group Operator Good day, and welcome to the PAVmed Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode.
PAVmed Inc. (PAVM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
PAVmed Inc. (NASDAQ:PAVM ) Q2 2023 Earnings Conference Call August 16, 2023 8:30 AM ET Company Participants Michael Parks - Vice President of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Ed Woo - Ascendiant Capital Ross Osborn - Cantor Fitzgerald Anthony Vendetti - Maxim Group Operator Good day, and welcome to the PAVmed Second Quarter 2023 Business Update Conference Call. [Operator Instructions] Please note, today's event is being recorded.
What type of business is PAVmed?
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
What sector is PAVmed in?
PAVmed is in the Healthcare sector
What industry is PAVmed in?
PAVmed is in the Medical Devices industry
What country is PAVmed from?
PAVmed is headquartered in United States
When did PAVmed go public?
PAVmed initial public offering (IPO) was on 27 July 2016
What is PAVmed website?
https://www.pavmed.com
Is PAVmed in the S&P 500?
No, PAVmed is not included in the S&P 500 index
Is PAVmed in the NASDAQ 100?
No, PAVmed is not included in the NASDAQ 100 index
Is PAVmed in the Dow Jones?
No, PAVmed is not included in the Dow Jones index
When does PAVmed report earnings?
The next expected earnings date for PAVmed is 16 August 2024